StonvexLoading…
StonvexStonvexStonvexCore line items from BCRX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $156.41M | $874.84M | $468.28M | $308.89M |
Operating Income | $-701.60M | $340.99M | $80.60M | $51.01M |
Net Income | $-721.81M | $263.86M | $18.02M | $5.08M |
EPS (Diluted) | $-2.98 | $1.21 | $0.08 | $0.02 |
Total Assets | $465.05M | $514.16M | $446.42M | $457.19M |
Total Liabilities | $1.02B | $633.31M | $834.31M | $878.78M |
Cash & Equivalents | $171.59M | $89.74M | $84.08M | $88.03M |
Free Cash Flow OCF − CapEx | $-62.19M | $344.90M | $53.74M | $13.46M |
Shares Outstanding | 254.01M | 213.06M | 210.52M | 209.91M |